PML interacts with Myc, and Myc target gene expression is altered in PML-null fibroblasts

Oncogene

Volumn 24, Issue 13, 2005, Pages 2195-2203

  Cairo, Stefano ^a   De Falco, Francesca ^a,c   Pizzo, Mariateresa ^a   Salomoni, Paolo ^b,d   Pandolfi, Pier Paolo ^b   Meroni, Germana ^a  

^a TELETHON INSTITUTE OF GENETICS AND MEDICINE TIGEM   (Italy)

^b Department of Molecular Biology and Genetics   (United States)

^c UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^d MRC TOXICOLOGY UNIT   (United Kingdom)

Author keywords

G1 phase; Gene expression; Myc; PML

Indexed keywords

COMPLEMENTARY DNA; GLUTATHIONE TRANSFERASE; HELIX LOOP HELIX PROTEIN; LEUCINE ZIPPER PROTEIN; RNA; TRANSCRIPTION FACTOR; MYC PROTEIN; NUCLEAR PROTEIN; PML PROTEIN, MOUSE; TUMOR PROTEIN; TUMOR SUPPRESSOR PROTEIN;

ANIMAL CELL; ARTICLE; DNA SEQUENCE; FIBROBLAST; GENE EXPRESSION; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; IMMUNOPRECIPITATION; NONHUMAN; ONCOGENE C MYC; PRIORITY JOURNAL; PROTO ONCOGENE; REAL TIME POLYMERASE CHAIN REACTION; ANIMAL; GENE EXPRESSION REGULATION; GENETIC TRANSFECTION; GENETICS; ISOLATION AND PURIFICATION; METABOLISM; MOUSE; ONCOGENE MYC; PHYSIOLOGY; POLYMERASE CHAIN REACTION; PROTEIN PROCESSING;

ANIMALS; FIBROBLASTS; GENE EXPRESSION REGULATION; GENES, MYC; MICE; NEOPLASM PROTEINS; NUCLEAR PROTEINS; POLYMERASE CHAIN REACTION; PROTEIN PROCESSING, POST-TRANSLATIONAL; PROTO-ONCOGENE PROTEINS C-MYC; RNA; TRANSCRIPTION FACTORS; TRANSFECTION; TUMOR SUPPRESSOR PROTEINS;

EID: 16444380896     PISSN: 09509232     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.onc.1208338     Document Type: Article

References (43)

1. Arabi A, Rustum C, Hallberg E and Wright AP. (2003). J. Cell Sci., 116, 1707-1717.
2. Best JL, Ganiatsas S, Agarwal S, Changou A, Salomoni P, Shirihai O, Meluh PB, Pandolfi PP and Zon LI. (2002). Mol. Cell, 10, 843-855.
3. Bischof O, Kirsh O, Pearson M, Itahana K, Pelicci PG and Dejean A. (2002). EMBO J., 21, 3358-3369.
4. Borden KL. (2002). Mol. Cell. Biol., 22, 5259-5269.
5. Boyd KE and Farnham PJ. (1997). Mol. Cell. Biol., 17, 2529-2537.
6. Chang KS, Fan YH, Andreeff M, Liu J and Mu ZM. (1995). Blood, 85, 3646-3653.
7. Chiang YC, Teng SC, Su YN, Hsieh FJ and Wu KJ. (2003). J. Biol. Chem., 278, 19286-19291.
8. de The H, Lavau C, Marchio A, Chomienne C, Degos L and Dejean A. (1991). Cell, 66, 675-684.
9. Fogal V, Gostissa M, Sandy P, Zacchi P, Sternsdorf T, Jensen K, Pandolfi PP, Will H, Schneider C and Del Sal G. (2000). EMBO J., 19, 6185-6195.
10. Gartel AL and Shchors K. (2003). Exp. Cell Res., 283, 17-21.
11. Goddard AD, Borrow J, Freemont PS and Solomon E. (1991). Science, 254, 1371-1374.
12. Grandori C, Wu KJ, Fernandez P, Ngouenet C, Grim J, Clurman BE, Moser MJ, Oshima J, Russell DW, Swisshelm K, Frank S, Amati B, Dalla-Favera R and Monnat Jr RJ. (2003). Genes Dev., 17, 1569-1574.
13. Henriksson M and Luscher B. (1996). Adv. Cancer Res., 68, 109-182.
14. Hodges M, Tissot C, Howe K, Grimwade D and Freemont PS. (1998). Am. J. Hum. Genet., 63, 297-304.
15. Ishov AM, Sotnikov AG, Negorev D, Vladimirova OV, Neff N, Kamitani T, Yeh ET, Strauss III JF and Maul GG. (1999). J. Cell Biol., 147, 221-234.
16. Kamemura K, Hayes BK, Comer FI and Hart GW. (2002). J. Biol. Chem., 277, 19229-19235.
17. Khan MM, Nomura T, Kim H, Kaul SC, Wadhwa R, Shinagawa T, Ichikawa-Iwata E, Zhong S, Pandolfi PP and Ishii S. (2001). Mol. Cell, 7, 1233-1243.
18. Kim SY, Herbst A, Tworkowski KA, Salghetti SE and Tansey WP. (2003). Mol. Cell, 11, 1177-1188.
19. Koken MH, Linares-Cruz G, Quignon F, Viron A, Chelbi-Alix MK, Sobczak-Thepot J, Juhlin L, Degos L, Calvo F and de The H. (1995). Oncogene, 10, 1315-1324.
20. Le Beau MM, Bitts S, Davis EM and Kogan SC. (2002). Blood, 99, 2985-2991.
21. Le Beau MM, Davis EM, Patel B, Phan VT, Sohal J and Kogan SC. (2003). Blood, 102, 1072-1074.
22. Levens DL. (2003). Genes Dev., 17, 1071-1077.
23. Liu JH, Mu ZM and Chang KS. (1995). J. Exp. Med., 181, 1965-1973.
24. Luscher B. (2001). Gene, 277, 1-14.
25. Luscher B and Larsson LG. (1999). Oncogene, 18, 2955-2966.
26. Mattsson K, Pokrovskaja K, Kiss C, Klein G and Szekely L. (2001). Proc. Natl. Acad. Sci. USA, 98, 1012-1017.
27. Moller A, Sirma H, Hofmann TG, Rueffer S, Klimczak E, Droge W, Will H and Schmitz ML. (2003). Cancer Res., 63, 4310-4314.
28. Naka K, Ikeda K and Motoyama N. (2002). Biochem. Biophys. Res. Commun., 299, 863-871.
29. Nesbit CE, Tersak JM and Prochownik EV. (1999). Oncogene, 18, 3004-3016.
30. Nikiforov MA, Popov N, Kotenko I, Henriksson M and Cole MD. (2003). J. Biol. Chem., 278, 11094-11099.
31. Pearson M, Carbone R, Sebastiani C, Cioce M, Fagioli M, Saito S, Higashimoto Y, Appella E, Minucci S, Pandolfi PP and Pelicci PG. (2000). Nature, 406, 207-210.
32. Reymond A, Meroni G, Fantozzi A, Merla G, Cairo S, Luzi L, Riganelli D, Zanaria E, Messali S, Cainarca S, Guffanti A, Minucci S, Pelicci PG and Ballabio A. (2001). EMBO J., 20, 2140-2151.
33. Salghetti SE, Kim SY and Tansey WP. (1999). EMBO J., 18, 717-726.
34. Salomoni P and Pandolfi PP. (2002). Cell, 108, 165-170.
35. Sears R, Nuckolls F, Haura E, Taya Y, Tamai K and Nevins JR. (2000). Genes Dev., 14, 2501-2514.
36. Seoane J, Le HV and Massague J. (2002). Nature, 419, 729-734.
37. Vervoorts J, Luscher-Firzlaff JM, Rottmann S, Lilischkis R, Walsemann G, Dohmann K, Austen M and Luscher B. (2003). EMBO Rep., 4, 484-490.
38. von der Lehr N, Johansson S, Wu S, Bahram F, Castell A, Cetinkaya C, Hydbring P, Weidung I, Nakayama K, Nakayama KI, Soderberg O, Kerppola TK and Larsson LG. (2003). Mol. Cell, 11, 1189-1200.
39. Wang ZG, Delva L, Gaboli M, Rivi R, Giorgio M, Cordon-Cardo C, Grosveld F and Pandolfi PP. (1998). Science, 279, 1547-1551.
40. Yin X, Landay MF, Han W, Levitan ES, Watkins SC, Levenson RM, Farkas DL and Prochownik EV. (2001). Oncogene, 20, 4650-4664.
41. Zhong S, Hu P, Ye TZ, Stan R, Ellis NA and Pandolfi PP. (1999). Oncogene, 18, 7941-7947.
42. Zhong S, Salomoni P and Pandolfi PP. (2000). Nat. Cell Biol., 2, E85-E90.
43. Zimonjic DB, Pollock JL, Westervelt P, Popescu NC and Ley TJ. (2000). Proc. Natl. Acad. Sci. USA, 97, 13306-13311.